Jennison Associates LLC Gilead Sciences, Inc. Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $34.3 Million - $37.5 Million	-540,103 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $32.4 Million - $37 Million	540,103 New	540,103 $34.9 Million
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $1.56 Million - $1.81 Million	-21,587 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $1.35 Million - $1.73 Million	21,587 New	21,587 $1.61 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $2.68 Million - $3.12 Million	-41,255 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$72.84 - $88.8 $2.42 Million - $2.95 Million	33,219 Added 413.38%	41,255 $3.11 Million
Q4 2017 Jan 25, 2018	SELL	$71.15 - $83.52 $1.14 Million - $1.33 Million	-15,969 Reduced 66.52%	8,036 $576,000
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $1.73 Million - $2.05 Million	24,005	24,005 $1.95 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.